Overall, the most commonly prescribed medications for patients with NASH in this study were vitamin E (53%), statins (51%), metformin (47%), angiotensin converting enzyme (ACE) inhibitors (28%), and beta blockers (22%). This evidence concerns the gene ACE and metabolic dysfunction-associated steatohepatitis.